We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Ariadne Licenses PathwayStudio® to UCB
News

Ariadne Licenses PathwayStudio® to UCB

Ariadne Licenses PathwayStudio® to UCB
News

Ariadne Licenses PathwayStudio® to UCB

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Ariadne Licenses PathwayStudio® to UCB "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Ariadne Genomics, Inc. has announced that UCB has licensed its PathwayStudio® software to support early stages of the drug discovery process - target identification and biomarker research.

PathwayStudio comes with ResNet™ database of 500,000+ functional relationships and MedScan™ modules for automatic extraction of information from scientific literature.

The software is designed to enable life science researchers to interpret their own discoveries in the context of biological pathways and gene regulation networks; it makes it easy to identify relationships among proteins, small molecules, cell processes and treatments, reconstruct pathways from microarray and proteomics data, identify biomarkers, and model drug responses.

"PathwayStudio being a client-server application offers pharmaceutical research groups easy and flexible team-wide access to the database, as well as the power of whole PubMed data at their fingertips," commented Ilya Mazo, President of Ariadne Genomics.

Advertisement